Answers are grounded in this paper and cite their sources.
Background: Thoracic aortic aneurysm and dissection (TAAD) can have catastrophic health consequences. Eleven genes have strong or definitive evidence for causing hereditary TAAD (HTAAD). However, patients are seldom tested for rare pathogenic (P) or likely pathogenic (LP) variants in these HTAAD genes, and little is known about their prevalence in the general population. The degree to which common genetic variation associated with TAAD modifies rare variant pathogenicity is unknown. Methods: Penn Medicine Biobank (PMBB) participants volunteered to have electronic health records linked to biospecimen data including DNA that has undergone genome-wide genotyping and whole exome sequencing. P/LP HTAAD gene variants were curated according to American College of Medical Genetics and Genomics standards and analyzed to determine the associated risk of TAAD. A TAAD polygenic risk score (PRS) was derived from a multi-trait genome-wide association study (GWAS) of TAAD and aortic diameter and analyzed to determine the modifying effect this PRS had on rare variant penetrance. Results: Of the 43,731 participants in the analytic cohort, 309 individuals carried a P/LP HTAAD gene variant, 79 (26%) of whom had a diagnosis of TAAD. Among non-carriers, 2,106 (4.9%) had a diagnosis of TAAD. Compared to individuals without a P/LP variant, those with a P/LP HTAAD variant had a 5.4-fold increased risk of a TAAD diagnosis (95% confidence interval [CI] 1.8 to 16.8, P =0.003). Similar results were seen among carriers stratified by individual HTAAD gene. Using a multi-trait GWAS to isolate the diameter-independent common genetic changes linked to TAAD, we constructed a PRS that strongly associated with TAAD in the PMBB (OR 1.70 per 1 s.d. increase in PRS, 95% CI 1.62 to 1.78, P <0.001). Finally, TAAD prevalence was increased among individuals carrying a P/LP HTAAD gene variant in the highest PRS quintile (38.2%, 95% CI 25.4% to 52.3%) compared to carriers in the lowest PRS quintile (8.9%, 95% CI 3.0% to 19.6%) suggesting that common variant risk modifies rare variant TAAD risk. Conclusions: Our results indicate that P/LP HTAAD gene variants confer a 5.4-fold increased risk of TAAD in the population at-large, and that common variant risk may be an important modifier of rare variant TAAD risk.
No takes yet. Share an insight, caveat, or question.
Depaolo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: